Osteoporosis - Study suggests Cx43 hemichannels as potential new target for osteoporosis treatments |
|
|
|
|
|
The latest osteoporosis news from News Medical |
|
|
|
| | Osteoporosis and Hearing Loss Osteoporosis is a common metabolic disorder that causes progressive changes in bone structure. This article looks at osteoporosis and hearing loss. | |
|
|
|
|
| | Patients with advanced chronic kidney disease (CKD) typically suffer from impaired bone quality and quantity, with a non-vertebral fracture risk which is 4-to 6-fold higher than the fracture risk of matched controls. However, despite their high risk of fragility fractures, the vast majority of patients with chronic CKD stages 4 to 5D, are not receiving osteoporosis therapy. | | | | Osteoporosis researchers at the UVA School of Medicine have taken a new approach to understanding how our genes determine the strength of our bones, allowing them to identify several genes not previously known to influence bone density and, ultimately, our risk of fracture. | | | | A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. | | | | University of South Australia researchers have a bone to pick when it comes to drinking too much coffee as new research finds that excess caffeine may be linked to an increased risk of osteoporosis. | |
|
|
|
|